Term ends Apr 22, 2027 · Low confidence
20-year base term ended Apr 28, 2026
Reissue of US 7,560,112, which was surrendered when this reissue was granted; its term and maintenance fees continue here.
Held by Janssen Biotech, Inc.
Filed Jul 8, 2011 as application 13/178,998 · Granted Sep 18, 2012
Base term plus 359 days of patent term adjustment (USPTO delay)
Today
2006
2027
Clock starts
Apr 28, 2006
Apr 28, 2006
Term ends
Apr 22, 2027
Apr 22, 2027
Granted
Sep 18, 2012
Sep 18, 2012
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
359
Days of term adjustment
Read from the original patent's USPTO patent term adjustment record, which governs a reissue. Not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from the original patent's grant (Jul 14, 2009). This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 359 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 28, 2006, when application 11/413,561, the earliest non-provisional in its chain, was filed (this one was filed Jul 8, 2011) | Apr 28, 2026 | High confidence |
| Continuity chain | A reissue: its term follows the original patent's, with the original's term adjustment | follows the original patent | Medium confidence |
| Patent term adjustment | +359 days, the original patent's USPTO patent term adjustment record, which governs a reissue (35 U.S.C. 251). This reissue's own record carries none | Apr 22, 2027 | Medium confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 22, 2027 | Low confidence |
This family
| US 7,560,112 | Surrendered on reissue Sep 2012 | Sep 2012 |
| US 7,833,755 | Term ended Apr 2026 | Apr 2026 |
| US 8,067,003 | Term ended Apr 2026 | Apr 2026 |
| US RE43,672 | this patent Apr 2027 | Apr 2027 |
| US 8,226,611 | Term ended Apr 2026 | Apr 2026 |
| US 8,623,362 | Term ended no later than Apr 2026 | no later than Apr 2026 |
| US 9,340,613 | Term ended Aug 2026 | Aug 2026 |
| US 9,631,016 | Term ended Apr 2026 | Apr 2026 |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 6, 2012 Reel 27493, frame 310 | Centocor Ortho Biotech Inc. | Janssen Biotech, Inc. | Change of Name |
| May 1, 2012 Reel 28137, frame 551 | Centocor, Inc. | Ortho Biotech, Inc. | Merger |
| Jan 31, 2019 Reel 48223, frame 122 | Centocor Ortho Biotech Inc. | Janssen Biotech, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Apr 2027
Term ends Apr 22, 2027. No further fees fall due before then
Note
The 359 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
51
later US patents cite this one
That is top 25% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.